Who owns Ascendis Pharma A/S (ASN)? Elite investor 13F holders
3 tracked elite investors reported holding Ascendis Pharma A/S as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | ASCENDIS PHARMA A/S | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 31926117.00 USD | 119699.000000 | Shares | buy | Original filing |
| Renaissance Technologies LLC | Ascendis Pharma A/S | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| D.E. Shaw | ASCENDIS PHARMA A/S | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 8237114.00 USD | 30883.000000 | Shares | buy | Original filing |
| Polen Capital Management | Ascendis Pharma A/S | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| D.E. Shaw | Ascendis Pharma A/S | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Ancora Advisors / Ancora Holdings | ASCENDIS PHARMA A/S | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3201.00 USD | 12.000000 | Shares | buy | Original filing |
| Ancora Advisors / Ancora Holdings | Ascendis Pharma A/S | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.